Fig. 2From: Use of Antidiabetic drugs during pregnancy among U.S. women with Livebirth deliveries in the Mini-Sentinel systemAntidiabetic drug use, by trimester, in the cohort of pregnancies among women with no prior ADD use during 2001–2013 in the MSDD. †1st Tri, 2nd Tri, and 3rd Tri refer to the three gestational trimesters, calculated using the pregnancy period algorithm based on delivery codes. Individual pregnancies could be counted in multiple gestational terms and for multiple drug categories. ‡ Other category includes alpha-glucosidase inhibitors, meglitinide analogs, amylin analog, DPP-4 inhibitors, GLP-1 receptor agonists, thiazolidinediones, and combination productsBack to article page